Krsnaa Diagnostics shares touched a 52-week high of Rs 901.10, rising more than 3 percent early on October 11 after the company signed agreements to provide radiology and pathology services.
At 09:20 am, Krsnaa Diagnostics was quoting at Rs 890.05, up Rs 29.55, or 3.43 percent, on the BSE, and extended the gains on the fourth consecutive day.
The company has received the signed agreement from the Medical Superintendent, Sadar Hospital, Ranchi, Jharkhand for the commission, installation, operation, and maintain the Radiology Services (CT and MRI) on a public-private partnership (PP) basis at Sadar Hospital, Purulia Road, Ranchi.
Also, the company has received the signed agreement from the Ranchi Institute of Neuro-Psychiatry & Allied Services (RINPAS), for supply, install, commission, operate, and maintain the Radiology Center (CT & MRI) and Pathology Laboratory services on a PPP basis at Ranchi Institute of neuro-psychiatry & allied sciences, Government of Jharkhand, India.
In September, the company announced plans to acquire a 23.53 percent stake in start-up Apulki Healthcare for exclusive rights to provide diagnostics services.
The share touched a 52-week high of Rs 887.95 and a 52-week low of Rs 527.55 on 23 September 2024 and 05 June 2024, respectively.
Currently, the stock is trading 3.09 percent below its 52-week high and 63.11 percent above its 52-week low.
0 Comment